Literature DB >> 20880176

Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting.

Monika Janda1, Karen L Hughes, Josephine F Auster, Barbara A Leggett, Beth M Newman.   

Abstract

BACKGROUND AND AIM: To investigate participation in a second round of colorectal cancer screening using a fecal occult blood test (FOBT) in an Australian rural community, and to assess the demographic characteristics and individual perspectives associated with repeat screening.
METHODS: Potential participants from round 1 (50-74 years of age) were sent an intervention package and asked to return a completed FOBT (n = 3406). Doctors of participants testing positive referred to colonoscopy as appropriate. Following screening, 119 participants completed qualitative telephone interviews. Multivariable logistic regression models evaluated the association between round-2 participation and other variables.
RESULTS: Round-2 participation was 34.7%; the strongest predictor was participation in round 1. Repeat participants were more likely to be female; inconsistent screeners were more likely to be younger (aged 50-59 years). The proportion of positive FOBT was 12.7%, that of colonoscopy compliance was 98.6%, and the positive predictive value for cancer or adenoma of advanced pathology was 23.9%. Reasons for participation included testing as a precautionary measure or having family history/friends with colorectal cancer; reasons for non-participation included apathy or doctors' advice against screening.
CONCLUSION: Participation was relatively low and consistent across rounds. Unless suitable strategies are identified to overcome behavioral trends and/or to screen out ineligible participants, little change in overall participation rates can be expected across rounds.
© 2010 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20880176     DOI: 10.1111/j.1440-1746.2010.06405.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Third Annual Fecal Occult Blood Testing in Community Health Clinics.

Authors:  Connie L Arnold; Alfred Rademaker; Michael S Wolf; Dachao Liu; Jill Hancock; Terry C Davis
Journal:  Am J Health Behav       Date:  2016-05

2.  Changes in Colorectal Cancer Screening Knowledge, Behavior, Beliefs, Self-Efficacy, and Barriers among Community Health Clinic Patients after a Health Literacy Intervention.

Authors:  Connie L Arnold; Alfred Rademaker; Dachao Liu; Terry C Davis
Journal:  J Community Med Health Educ       Date:  2017-01-13

3.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

4.  Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.

Authors:  Amit G Singal; Samir Gupta; Celette Sugg Skinner; Chul Ahn; Noel O Santini; Deepak Agrawal; Christian A Mayorga; Caitlin Murphy; Jasmin A Tiro; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Adam C Loewen; Ethan A Halm
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

5.  The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.

Authors:  Rachel Gingold-Belfer; Haim Leibovitzh; Doron Boltin; Nidal Issa; Tsachi Tsadok Perets; Ram Dickman; Yaron Niv
Journal:  United European Gastroenterol J       Date:  2019-02-06       Impact factor: 4.623

6.  Strategies to improve repeat fecal occult blood testing cancer screening.

Authors:  Terry C Davis; Connie L Arnold; Charles L Bennett; Michael S Wolf; Cristalyn Reynolds; Dachao Liu; Alfred Rademaker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-05       Impact factor: 4.254

7.  Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.

Authors:  Carrie M Nielson; William M Vollmer; Amanda F Petrik; Erin M Keast; Beverly B Green; Gloria D Coronado
Journal:  J Gen Intern Med       Date:  2019-01-25       Impact factor: 5.128

8.  Final Results of a 3-Year Literacy-Informed Intervention to Promote Annual Fecal Occult Blood Test Screening.

Authors:  Connie L Arnold; Alfred Rademaker; Michael S Wolf; Dachao Liu; Geoffrey Lucas; Jill Hancock; Terry C Davis
Journal:  J Community Health       Date:  2016-08

9.  Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.

Authors:  Amit G Singal; Samir Gupta; Jasmin A Tiro; Celette Sugg Skinner; Katharine McCallister; Joanne M Sanders; Wendy Pechero Bishop; Deepak Agrawal; Christian A Mayorga; Chul Ahn; Adam C Loewen; Noel O Santini; Ethan A Halm
Journal:  Cancer       Date:  2015-11-04       Impact factor: 6.860

10.  Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.

Authors:  Amit G Singal; Douglas A Corley; Aruna Kamineni; Michael Garcia; Yingye Zheng; Paul V Doria-Rose; Virginia P Quinn; Christopher D Jensen; Jessica Chubak; Jasmin Tiro; Chyke A Doubeni; Nirupa R Ghai; Celette Sugg Skinner; Karen Wernli; Ethan A Halm
Journal:  Am J Gastroenterol       Date:  2018-02-27       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.